Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,956 | -22,447 | -16,106 | -10,656 | -5,046 |
| Depreciation Amortization | 252 | 1,014 | 584 | 395 | 199 |
| Accounts payable and accrued liabilities | 72 | -329 | -306 | -185 | 274 |
| Other Working Capital | -1,048 | -509 | -882 | 36 | -1,264 |
| Other Operating Activity | 1,030 | 4,903 | 3,651 | 2,576 | 1,173 |
| Operating Cash Flow | $-4,651 | $-17,368 | $-13,060 | $-7,833 | $-4,665 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,817 | -40,661 | -49,751 | -46,971 | -54,962 |
| PPE Investments | N/A | -6 | -6 | -6 | -6 |
| Investing Cash Flow | $8,817 | $-40,667 | $-49,756 | $-46,976 | $-54,968 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8 | -55 | -47 | -36 | -20 |
| Common Stock Issued | 6,793 | 48,102 | 47,544 | 47,479 | 47,459 |
| Financing Cash Flow | $6,785 | $48,047 | $47,497 | $47,443 | $47,439 |
| Beginning Cash Position | 12,769 | 22,756 | 22,756 | 22,756 | 22,756 |
| End Cash Position | 23,719 | 12,769 | 7,437 | 15,390 | 10,564 |
| Net Cash Flow | $10,950 | $-9,988 | $-15,319 | $-7,367 | $-12,193 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,651 | -17,368 | -13,060 | -7,833 | -4,665 |
| Capital Expenditure | N/A | -6 | -6 | -6 | -6 |
| Free Cash Flow | -4,651 | -17,374 | -13,066 | -7,839 | -4,670 |